Zalunfiban shows early benefits in ST-elevation heart attacks

[ad_1]

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug zalunfiban given at first medical contact for suspected ST-elevation myocardial infarction (STEMI) improved early blood flow in the blocked artery and reduced the chance of a worse 30-day combined outcome.

[ad_2]

Source link